TW
CELG

Transform Wealth’s Celgene Corp CELG Stock Holding History

Transform Wealth’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,000
Closed -$894K – 210
2018
Q3 		$894K Buy
+10,000
New +$884K 0.16% 129
2018
Q2 		– Sell
-10,030
Closed -$895K – 241
2018
Q1 		$895K Sell
10,030
-11,303
-53% -$1.09M 0.17% 146
2017
Q4 		$2.23M Buy
21,333
+12,270
+135% +$1.38M 0.41% 82
2017
Q3 		$1.32M Buy
9,063
+162
+2% +$22.1K 0.46% 77
2017
Q2 		$1.16M Buy
8,901
+887
+11% +$109K 1.3% 31
2017
Q1 		$997K Buy
8,014
+904
+13% +$108K 0.37% 99
2016
Q4 		$823K Buy
+7,110
New +$792K 0.33% 105

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Transform Wealth's CELG Position: Q4 2018 in Review

Transform Wealth sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 10,000 shares — an estimated $894K sold.

Transform Wealth first reported a position in CELG in Q4 2016 and held it in 7 quarters. The position peaked at $2.23M in Q4 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Transform Wealth reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Transform Wealth sold 10,000 Celgene Corp shares in Q4 2018, an estimated $894K.
  • Transform Wealth first reported a position in Celgene Corp in Q4 2016 and held it in 7 quarters.
  • Transform Wealth's Celgene Corp position peaked at $2.23M in Q4 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Transform Wealth's 13F filing for Q4 2018, filed 30 Jan 2019.